Fiduciary Trust’s Exelon EXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,390
| Closed | -$279K | – | 627 |
|
|
2023
Q3 | $279K | Sell |
7,390
-230
| -3% | -$9.37K | 0.01% | 538 |
|
|
2023
Q2 | $310K | Sell |
7,620
-1,168
| -13% | -$48.3K | 0.01% | 532 |
|
|
2023
Q1 | $368K | Sell |
8,788
-1
| -0% | -$42 | 0.01% | 501 |
|
|
2022
Q4 | $380K | Sell |
8,789
-842
| -9% | -$33.3K | 0.01% | 498 |
|
|
2022
Q3 | $360K | Sell |
9,631
-500
| -5% | -$22.1K | 0.01% | 489 |
|
|
2022
Q2 | $459K | Sell |
10,131
-1
| -0% | -$47 | 0.01% | 460 |
|
|
2022
Q1 | $482K | Sell |
10,132
-3,306
| -25% | -$140K | 0.01% | 479 |
|
|
2021
Q4 | $554K | Sell |
13,438
-526
| -4% | -$19.8K | 0.01% | 459 |
|
|
2021
Q3 | $481K | Sell |
13,964
-357
| -2% | -$12.2K | 0.01% | 480 |
|
|
2021
Q2 | $452K | Sell |
14,321
-607
| -4% | -$19.5K | 0.01% | 480 |
|
|
2021
Q1 | $466K | Sell |
14,928
-355
| -2% | -$10.7K | 0.01% | 464 |
|
|
2020
Q4 | $460K | Hold |
15,283
| – | – | 0.01% | 445 |
|
|
2020
Q3 | $390K | Buy |
15,283
+377
| +3% | +$9.99K | 0.01% | 442 |
|
|
2020
Q2 | $386K | Sell |
14,906
-753
| -5% | -$20K | 0.01% | 420 |
|
|
2020
Q1 | $411K | Sell |
15,659
-671
| -4% | -$21.1K | 0.01% | 372 |
|
|
2019
Q4 | $531K | Buy |
16,330
+196
| +1% | +$6.35K | 0.01% | 370 |
|
|
2019
Q3 | $556K | Buy |
16,134
+331
| +2% | +$11.1K | 0.01% | 355 |
|
|
2019
Q2 | $540K | Buy |
15,803
+1,947
| +14% | +$68.7K | 0.01% | 347 |
|
|
2019
Q1 | $495K | Sell |
13,856
-350
| -2% | -$11.9K | 0.01% | 349 |
|
|
2018
Q4 | $457K | Sell |
14,206
-211
| -1% | -$6.75K | 0.01% | 334 |
|
|
2018
Q3 | $449K | Hold |
14,417
| – | – | 0.01% | 349 |
|
|
2018
Q2 | $439K | Sell |
14,417
-1,490
| -9% | -$42.7K | 0.01% | 343 |
|
|
2018
Q1 | $442K | Buy |
15,907
+7,189
| +82% | +$194K | 0.01% | 336 |
|
|
2017
Q4 | $245K | Sell |
8,718
-849
| -9% | -$24.4K | 0.01% | 393 |
|
|
2017
Q3 | $257K | Sell |
9,567
-921
| -9% | -$24.6K | 0.01% | 392 |
|
|
2017
Q2 | $270K | Buy |
10,488
+21
| +0.2% | +$534 | 0.01% | 397 |
|
|
2017
Q1 | $268K | Sell |
10,467
-581
| -5% | -$14.8K | 0.01% | 396 |
|
|
2016
Q4 | $280K | Sell |
11,048
-889
| -7% | -$21.1K | 0.01% | 391 |
|
|
2016
Q3 | $284K | Sell |
11,937
-1,362
| -10% | -$34.2K | 0.01% | 391 |
|
|
2016
Q2 | $345K | Sell |
13,299
-2,235
| -14% | -$55.3K | 0.01% | 364 |
|
|
2016
Q1 | $397K | Sell |
15,534
-131
| -0.8% | -$2.94K | 0.01% | 350 |
|
|
2015
Q4 | $310K | Sell |
15,665
-2,846
| -15% | -$57.7K | 0.01% | 328 |
|
|
2015
Q3 | $392K | Sell |
18,511
-1,437
| -7% | -$32.3K | 0.02% | 298 |
|
|
2015
Q2 | $447K | Hold |
19,948
| – | – | 0.02% | 270 |
|
|
2015
Q1 | $479K | Sell |
19,948
-8,789
| -31% | -$218K | 0.02% | 266 |
|
|
2014
Q4 | $760K | Sell |
28,737
-1,567
| -5% | -$40.2K | 0.03% | 230 |
|
|
2014
Q3 | $737K | Sell |
30,304
-5,474
| -15% | -$128K | 0.03% | 209 |
|
|
2014
Q2 | $931K | Sell |
35,778
-1,076
| -3% | -$27.4K | 0.04% | 197 |
|
|
2014
Q1 | $882K | Sell |
36,854
-1,367
| -4% | -$28.8K | 0.04% | 195 |
|
|
2013
Q4 | $747K | Sell |
38,221
-6,925
| -15% | -$139K | 0.03% | 199 |
|
|
2013
Q3 | $954K | Sell |
45,146
-7,297
| -14% | -$160K | 0.04% | 176 |
|
|
2013
Q2 | $1.16M | Buy |
+52,443
| New | +$1.27M | 0.05% | 169 |
|
Other funds holding EXC
Fiduciary Trust's EXC Position: Q4 2023 in Review
Fiduciary Trust sold out of Exelon (EXC) in Q4 2023, closing a stake of 7,390 shares — an estimated $279K sold.
Fiduciary Trust first reported a position in EXC in Q2 2013 and held it in 42 quarters. The position peaked at $1.16M in Q2 2013. 1,017 funds tracked by Wall St. Rank hold EXC as of Q4 2023.
- Fiduciary Trust reported no remaining Exelon position as of Q4 2023 after selling out during the quarter.
- Fiduciary Trust sold 7,390 Exelon shares in Q4 2023, an estimated $279K.
- Fiduciary Trust first reported a position in Exelon in Q2 2013 and held it in 42 quarters.
- Fiduciary Trust's Exelon position peaked at $1.16M in Q2 2013.
- 1,017 funds tracked by Wall St. Rank held Exelon as of Q4 2023.
Based on Fiduciary Trust's 13F filing for Q4 2023, filed 12 Feb 2024.